Prolactinoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}}{{Anmol}} | |||
==Overview== | ==Overview== | ||
Revision as of 20:40, 19 July 2017
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Prolactinoma differential diagnosis |
|
Risk calculators and risk factors for Prolactinoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Prolactinoma must be differentiated from other causes of hyperprolactinemia such as hypothyroidism, antipsychotics and antidepressants.
Differential Diagnosis
Prolactinoma must be differentiated from other causes of hyperprolactinemia including:
- Pituitary tumors (other than prolactinoma)[1]
- Somatotroph adenoma: Acromegaly
- Corticotroph adenoma: Cushing's syndrome
- Hypothyroidism
- Normal pregnancy
- Seizure disorder
- Adverse effects of antipsychotic medications:
References
- ↑ Levy A (2004). "Pituitary disease: presentation, diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii47–52. doi:10.1136/jnnp.2004.045740. PMC 1765669. PMID 15316045.